Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Other Accumulated Expenses (2022 - 2025)

Neuraxis (NRXS) has disclosed Other Accumulated Expenses for 4 consecutive years, with $108191.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 270.85% to $108191.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108191.0 through Dec 2025, up 270.85% year-over-year, with the annual reading at $108191.0 for FY2025, 270.85% up from the prior year.
  • Other Accumulated Expenses hit $108191.0 in Q4 2025 for Neuraxis, up from $37770.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $155351.0 in Q1 2025 to a low of $777.0 in Q4 2022.
  • Historically, Other Accumulated Expenses has averaged $48263.4 across 4 years, with a median of $39515.5 in 2023.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 4267.7% in 2024 and later plummeted 33.02% in 2025.
  • Year by year, Other Accumulated Expenses stood at $777.0 in 2022, then rose by 23.94% to $963.0 in 2023, then soared by 2929.49% to $29174.0 in 2024, then skyrocketed by 270.85% to $108191.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for NRXS at $108191.0 in Q4 2025, $37770.0 in Q3 2025, and $63996.0 in Q2 2025.